GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Nanjing Well Pharmaceutical Group Co Ltd (SHSE:603351) » Definitions » Short-Term Debt

Nanjing Well Pharmaceutical Group Co (SHSE:603351) Short-Term Debt : ¥417 Mil (As of Mar. 2025)


View and export this data going back to 2019. Start your Free Trial

What is Nanjing Well Pharmaceutical Group Co Short-Term Debt?

Nanjing Well Pharmaceutical Group Co's Short-Term Debt for the quarter that ended in Mar. 2025 was ¥417 Mil.

Nanjing Well Pharmaceutical Group Co's quarterly Short-Term Debt increased from Sep. 2024 (¥331 Mil) to Dec. 2024 (¥376 Mil) and increased from Dec. 2024 (¥376 Mil) to Mar. 2025 (¥417 Mil).

Nanjing Well Pharmaceutical Group Co's annual Short-Term Debt increased from Dec. 2022 (¥360 Mil) to Dec. 2023 (¥362 Mil) and increased from Dec. 2023 (¥362 Mil) to Dec. 2024 (¥376 Mil).

Nanjing Well Pharmaceutical Group Co Short-Term Debt Historical Data

The historical data trend for Nanjing Well Pharmaceutical Group Co's Short-Term Debt can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Nanjing Well Pharmaceutical Group Co Short-Term Debt Chart

Nanjing Well Pharmaceutical Group Co Annual Data
Trend Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
Short-Term Debt
Get a 7-Day Free Trial Premium Member Only Premium Member Only 90.13 171.19 360.45 362.22 376.20

Nanjing Well Pharmaceutical Group Co Quarterly Data
Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25
Short-Term Debt Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 344.46 403.61 331.19 376.20 417.19

Nanjing Well Pharmaceutical Group Co Short-Term Debt Explanation

Short-Term Debt represents the total amount of Long-Term Debt such as bank loans and commercial paper, which is due within one year.

Nanjing Well Pharmaceutical Group Co Short-Term Debt Related Terms

Thank you for viewing the detailed overview of Nanjing Well Pharmaceutical Group Co's Short-Term Debt provided by GuruFocus.com. Please click on the following links to see related term pages.

Nanjing Well Pharmaceutical Group Co Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Nanjing Well Pharmaceutical Group Co Ltd (SHSE:603351) » Definitions » Short-Term Debt
Comparable Companies
SZSE:301509 SZSE:002365 SHSE:688073 SZSE:300158 SZSE:300485 SHSE:688373 SZSE:002644 SZSE:002923 SHSE:600530 SZSE:300111 ZTS XTER:MRK NSE:SUNPHARMA TSE:4502 LSE:HLN XSWX:GALD NSE:DIVISLAB HKSE:03692 XSWX:SDZ XTAE:TEVA
Traded in Other Exchanges
N/A
Address
No. 99, Changfeng Hexi Road, Nanjing Chemical Industry Park, Jiangsu Province, Nanjing, CHN, 210000
Website
http://www.well-js.com
Nanjing Well Pharmaceutical Group Co Ltd is engaged in research and development, production and sales of pharmaceutical auxiliary materials and synthetic lubricating base oil and other products. The company uses a variety of pharmaceutical dosage forms such as injection, oral administration and external use to guarantee the molding, effectiveness, stability and safety of pharmaceutical dosage forms.
Executives
Zou Jian Guo senior management
Wang Fu Qiu Directors, senior managers
Wu Rong Wen Supervisors

Nanjing Well Pharmaceutical Group Co Headlines

No Headlines